Efficacy and safety of glecaprevir/pibrentasvir in patients with chronic HCV infection and psychiatric disorders: An integrated analysis

Although direct‐acting antivirals (DAAs) for chronic hepatitis C virus (HCV) infection are highly efficacious and safe, treatment initiation is often limited in patients with neuropsychiatric disorders due to concerns over reduced treatment adherence and drug–drug interactions. Here, we report adher...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:J Viral Hepat
Autors principals: Back, David, Belperio, Pamela, Bondin, Mark, Negro, Francesco, Talal, Andrew H., Park, Caroline, Zhang, ZhenZhen, Pinsky, Brett, Crown, Eric, Mensa, Federico J., Marra, Fiona
Format: Artigo
Idioma:Inglês
Publicat: John Wiley and Sons Inc. 2019
Matèries:
Original Articles
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC6852431/
https://ncbi.nlm.nih.gov/pubmed/30977945
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/jvh.13110
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars